GSK Investigational Site

Mendoza, Mendoza Province M5500CCG

0 studies enrolling now · 9 studies all time

What they study most

Asthma, Diabetes Mellitus, Type 2, Nausea, Nausea and Vomiting, Chemotherapy-Induced, Pulmonary Disease, Chronic Obstructive, Vomiting

Studies at this site

• 24-week Trial Comparing GSK573719/GW642444 With GSK573719 and With Tiotropium in Chronic Obstructive Pulmonary Disease — Completed
• HZA113091 Efficacy and Safety of Fluticasone Furoate/Vilanterol (GW642444) in Adults and Adolescents — Completed
• Evaluating the Efficacy and Safety of Fluticasone Furoate in the Treatment of Asthma in Adults and Adolescents — Completed
• Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children — Completed
• A Study To Assess Efficacy And Safety Of Different Doses Of GW642444 In Subjects With Chronic Obstructive Pulmonary Disease (COPD) — Completed
• Efficacy And Safety Of GW642444M Comparing Placebo In Adolescent And Adult Subjects With Persistent Asthma. — Completed
• A 12-Month Study Comparing Fluticasone Propionate/Salmeterol (ADVAIR) DISKUS Combination Product 250/50mcg Twice Daily To Fluticasone Propionate (FLOVENT) DISKUS 250 mcg Twice Daily In Symptomatic Patients With Asthma — Completed
• A Type 2 Diabetes Study of the Longer-Term Glycemic Effect of AVANDAMET vs. Metformin — Completed
• Intravenous And Oral Casopitant (GW679769) For The Prevention Of Chemotherapy Induced Nausea And Vomiting — Completed